Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 7
Submit an article Journal homepage
304
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Growth hormone: does it have a therapeutic role in fracture healing?

Gui Tong Tran University of Leeds School of Medicine, Academic Department of Trauma and Orthopaedics, Leeds General Infirmary, Great George Street, Leeds, UK
,
Joseph Pagkalos University of Leeds School of Medicine, Academic Department of Trauma and Orthopaedics, Leeds General Infirmary, Great George Street, Leeds, UK
,
Evgenios Tsiridis Blue Cross Hospital, Cardio-Thoracic Anaesthetic Unit, Thessaloniki, Greece
,
Amir Ali Narvani University of Leeds School of Medicine, Academic Department of Trauma and Orthopaedics, Leeds General Infirmary, Great George Street, Leeds, UK
,
Manolis Heliotis Northwick Patrick Hospital, Maxillofacial Unit, Wattford Road, Harrow, London, UK
,
Athanasios Mantalaris Imperial College London, Department of Chemical Engineering, South Kensington Campus, London, UK
&
Eleftherios Tsiridis Leeds General Infirmary, Department of Orthopaedics, Great George Street, Leeds LS1 3EX, UK +44 01133922621; +44 01133922621; [email protected]
 show all
Pages 887-911 | Published online: 31 May 2009

Bibliography

  • Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19(6):717-97
  • Stracke H, Schulz A, Moeller D, et al. Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. Acta Endocrinol (Copenh) 1984;107(1):16-24
  • Sjogren K, Liu JL, Blad K, et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 1999;96(12):7088-92
  • Wabitsch M, Heinze E, Debatin KM, Blum WF. IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm Metab Res 2000;32(11-12):555-9
  • Isgaard J, Moller C, Isaksson OG, et al. Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. Endocrinology 1988;122(4):1515-20
  • Canalis E, McCarthy T, Centrella M. Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae. Endocrinology 1988;122(1):22-7
  • Daughaday WH, Hall K, Raben MS, et al. Somatomedin: proposed designation for sulphation factor. Nature 1972;235(5333):107
  • Schoenle E, Zapf J, Humbel RE, Froesch ER. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 1982;296(5854):252-3
  • Russell SM, Spencer EM. Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology 1985;116(6):2563-7
  • Isaksson OG, Jansson JO, Gause IA. Growth hormone stimulates longitudinal bone growth directly. Science 1982;216(4551):1237-9
  • Kassem M, Blum W, Ristelli J, et al. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 1993;52(3):222-6
  • Maor G, Hochberg Z, von der Mark K, et al. Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 1989;125(3):1239-45
  • Nilsson A, Isgaard J, Lindahl A, et al. Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats. Calcif Tissue Int 1987;40(2):91-6
  • Schlechter NL, Russell SM, Greenberg S, et al. A direct growth effect of growth hormone in rat hindlimb shown by arterial infusion. Am J Physiol 1986;250(3 Pt 1):E231-5
  • Green H, Morikawa M, Nixon T. A dual effector theory of growth-hormone action. Differentiation 1985;29(3):195-8
  • Hazel SJ, Gillespie CM, Moore RJ, et al. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. Kidney Int 1994;46(1):58-68
  • Schmidmaier G, Wildemann B, Heeger J, et al. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1. Bone 2002;31(1):165-72
  • Wang J, Zhou J, Cheng CM, et al. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 2004;180(2):247-55
  • Morel G, Chavassieux P, Barenton B, et al. Evidence for a direct effect of growth hormone on osteoblasts. Cell Tissue Res 1993;273(2):279-86
  • Scheven BA, Hamilton NJ, Fakkeldij TM, Duursma SA. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul 1991;1(4):160-7
  • Lewinson D, Shenzer P, Hochberg Z. Growth hormone involvement in the regulation of tartrate-resistant acid phosphatase-positive cells that are active in cartilage and bone resorption. Calcif Tissue Int 1993;52(3):216-21
  • Nishiyama K, Sugimoto T, Kaji H, et al. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 1996;137(1):35-41
  • Johannsson G, Rosen T, Bosaeus I, et al. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996;81(8):2865-73
  • Murphy MG, Bach MA, Plotkin D, et al. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group. J Bone Miner Res 1999;14(7):1182-8
  • Zhao G, Monier-Faugere MC, Langub MC, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000;141(7):2674-82
  • Tanaka H, Moriwake T, Matsuoka Y, et al. Potential role of rhIGF-I/IGFBP-3 in maintaining skeletal mass in space. Bone 1998;22(5 Suppl):145S-7S
  • Delany AM, Rydziel S, Canalis E. Autocrine down-regulation of collagenase-3 in rat bone cell cultures by insulin-like growth factors. Endocrinology 1996;137(11):4665-70
  • Santhanagopal A, Dixon SJ. Insulin-like growth factor I rapidly enhances acid efflux from osteoblastic cells. Am J Physiol 1999;277(3 Pt 1):E423-32
  • Mochizuki H, Hakeda Y, Wakatsuki N, et al. Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 1992;131(3):1075-80
  • Langlois JA, Rosen CJ, Visser M, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998;83(12):4257-62
  • Qutob S, Dixon SJ, Wilson JX. Insulin stimulates vitamin C recycling and ascorbate accumulation in osteoblastic cells. Endocrinology 1998;139(1):51-6
  • Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab 2001;12(6):252-7
  • Werther GA, Haynes K, Edmonson S, et al. Identification of growth hormone receptors on human growth plate chondrocytes. Acta Paediatr Suppl 1993;82(Suppl 391):50-3
  • Barnard R, Ng KW, Martin TJ, Waters MJ. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 1991;128(3):1459-64
  • Xiao G, Gopalakrishnan R, Jiang D, et al. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17(1):101-10
  • Ghosh-Choudhury N, Abboud SL, Nishimura R, et al. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 2002;277(36):33361-8
  • Ishisaki A, Tokuda H, Yoshida M, et al. Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts. Mol Cell Endocrinol 2004;214(1-2):189-95
  • Wu JB, Fong YC, Tsai HY, et al. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol 2008;588(2-3):333-41
  • Tsialogiannis E, Polyzois I, Oak Tang Q, et al. Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin Ther Targets 2009;13(1):123-37
  • Herrington J, Smit LS, Schwartz J, Carter-Su C. The role of STAT proteins in growth hormone signaling. Oncogene 2000;19(21):2585-97
  • Cesena TI, Cui TX, Piwien-Pilipuk G, et al. Multiple mechanisms of growth hormone-regulated gene transcription. Mol Genet Metab 2007;90(2):126-33
  • Love DW, Whatmore AJ, Clayton PE, Silva CM. Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology 1998;139(4):1965-71
  • Edens A, Talamantes F. Alternative processing of growth hormone receptor transcripts. Endocr Rev 1998;19(5):559-82
  • Zhang Y, Jiang J, Black RA, et al. Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 2000;141(12):4342-8
  • Schantl JA, Roza M, Van Kerkhof P, Strous GJ. The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE). Biochem J 2004;377(Pt 2):379-84
  • Fisker S. Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects. Growth Horm IGF Res 2006;16(1):1-28
  • Bichell DP, Kikuchi K, Rotwein P. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol Endocrinol 1992;6(11):1899-908
  • Woelfle J, Chia DJ, Massart-Schlesinger MB, et al. Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system. Pediatr Nephrol 2005;20(3):295-302
  • Sims NA, Clement-Lacroix P, Da Ponte F, et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 2000;106(9):1095-103
  • Wei S, Tanaka H, Kubo T, et al. Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol 1997;136(1):45-51
  • Kurose H, Yamaoka K, Okada S, et al. 1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells. Study on interaction of IGF-I and 1,25-(OH)2D3. Endocrinology 1990;126(4):2088-94
  • LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16(2):143-63
  • Denley A, Cosgrove LJ, Booker GW, et al. Molecular interactions of the IGF system. Cytokine Growth Factor Rev 2005;16(4-5):421-39
  • Lowenstein EJ, Daly RJ, Batzer AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992;70(3):431-42
  • Xiao S, Rose DW, Sasaoka T, et al. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem 1994;269(33):21244-8
  • Li W, Nishimura R, Kashishian A, et al. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol 1994;14(1):509-17
  • Fatayerji D, Mawer EB, Eastell R. The role of insulin-like growth factor I in age-related changes in calcium homeostasis in men. J Clin Endocrinol Metab 2000;85(12):4657-62
  • Playford MP, Bicknell D, Bodmer WF, Macaulay VM. Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci USA 2000;97(22):12103-8
  • Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 2006;116(5):1202-9
  • Chen J, Wu A, Sun H, et al. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J Biol Chem 2005;280(33):29912-20
  • Borromeo V, Bramani S, Holder AT, et al. Growth hormone stimulates the secretion of insulin-like growth factor binding protein-2 (IGFBP-2) by monolayer cultures of sheep costal growth plate chondrocytes. Mol Cell Biochem 1996;162(2):145-51
  • Feyen JH, Evans DB, Binkert C, et al. Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. J Biol Chem 1991;266(29):19469-74
  • Palermo C, Manduca P, Gazzerro E, et al. Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. Am J Physiol Endocrinol Metab 2004;286(4):E648-57
  • Ono T, Kanzaki S, Seino Y, et al. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab 1996;81(6):2111-6
  • Bagi CM, DeLeon E, Brommage R, et al. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats. Bone 1995;16(4 Suppl):263S-9S
  • Ricort JM, Binoux M. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity. Endocrinology 2001;142(1):108-13
  • Longobardi L, Torello M, Buckway C, et al. A novel insulin-like growth factor (IGF)-independent role for IGF binding protein-3 in mesenchymal chondroprogenitor cell apoptosis. Endocrinology 2003;144(5):1695-702
  • Baxter RC, Dai J. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 1994;134(2):848-52
  • Ooi GT, Cohen FJ, Tseng LY, et al. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver. Mol Endocrinol 1997;11(7):997-1007
  • Boisclair YR, Rhoads RP, Ueki I, et al. The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol 2001;170(1):63-70
  • Mohan S, Nakao Y, Honda Y, et al. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995;270(35):20424-31
  • Kanzaki S, Hilliker S, Baylink DJ, Mohan S. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 1994;134(1):383-92
  • Miyakoshi N, Qin X, Kasukawa Y, et al. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 2001;142(6):2641-8
  • Lawrence JB, Oxvig C, Overgaard MT, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999;96(6):3149-53
  • McCarthy TL, Casinghino S, Centrella M, Canalis E. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. J Cell Physiol 1994;160(1):163-75
  • Conover CA, Kiefer MC. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. J Clin Endocrinol Metab 1993;76(5):1153-9
  • Bautista CM, Baylink DJ, Mohan S. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 1991;176(2):756-63
  • Andress DL, Birnbaum RS. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 1992;267(31):22467-72
  • Bach LA. IGFBP-6 five years on; not so ‘forgotten’? Growth Horm IGF Res 2005;15(3):185-92
  • Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, Duursma SA. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinologica 1988;118(2):294-300
  • Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MP, et al. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. J Endocrinol 1988;116(3):R11-3
  • Argetsinger LS, Campbell GS, Yang X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993;74(2):237-44
  • Gerland K, Bataille-Simoneau N, Basle M, et al. Activation of the Jak/Stat signal transduction pathway in GH-treated rat osteoblast-like cells in culture. Mol Cell Endocrinol 2000;168(1-2):1-9
  • Huang Z, Cheng SL, Slatopolsky E. Sustained activation of the extracellular signal-regulated kinase pathway is required for extracellular calcium stimulation of human osteoblast proliferation. J Biol Chem 2001;276(24):21351-8
  • Lai CF, Chaudhary L, Fausto A, et al. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 2001;276(17):14443-50
  • DiGirolamo DJ, Mukherjee A, Fulzele K, et al. Mode of growth hormone action in osteoblasts. J Biol Chem 2007;282(43):31666-74
  • Crippa GE, Beloti MM, Cardoso CR, et al. Effect of growth hormone on in vitro osteogenesis and gene expression of human osteoblastic cells is donor-age-dependent. J Cell Biochem 2008;104(2):369-76
  • Mohan S, Richman C, Guo R, et al. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 2003;144(3):929-36
  • Zhang M, Xuan S, Bouxsein ML, et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 2002;277(46):44005-12
  • Canalis E, Lian JB. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 1988;9(4):243-6
  • Canalis E. Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria. J Clin Invest 1980;66(4):709-19
  • McCarthy TL, Centrella M, Canalis E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 1989;124(1):301-9
  • Canalis E, Rydziel S, Delany AM, et al. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 1995;136(4):1348-54
  • Farley JR, Stilt-Coffing B. Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells. Calcif Tissue Int 2001;68(1):43-52
  • Thomas T, Gori F, Spelsberg TC, et al. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 1999;140(11):5036-44
  • Lee MH, Kim YJ, Kim HJ, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003;278(36):34387-94
  • Komori T. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 2002;87(1):1-8
  • Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108(1):17-29
  • Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev 2001;2(10):760-8
  • Fujita T, Azuma Y, Fukuyama R, et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 2004;166(1):85-95
  • Celil AB, Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005;280(36):31353-9
  • Ziros PG, Georgakopoulos T, Habeos I, et al. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. J Bone Miner Res 2004;19(11):1892-904
  • Guicheux J, Heymann D, Rousselle AV, et al. Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. Bone 1998;22(1):25-31
  • Fiorelli G, Formigli L, Zecchi Orlandini S, et al. Characterization and function of the receptor for IGF-I in human preosteoclastic cells. Bone 1996;18(3):269-76
  • Hill PA, Reynolds JJ, Meikle MC. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 1995;136(1):124-31
  • Jonsson KB, Wiberg K, Ljunghall S, Ljunggren O. Insulin-like growth factor I does not stimulate bone resorption in cultured neonatal mouse calvarial bones. Calcif Tissue Int 1996;59(5):366-70
  • Burgess TL, Qian Y, Kaufman S, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 1999;145(3):527-38
  • Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15(1):2-12
  • Rubin J, Ackert-Bicknell CL, Zhu L, et al. IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. J Clin Endocr Metab 2002;87(9):4273-9
  • Mrak E, Villa I, Lanzi R, et al. Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells. J Endocrinol 2007;192(3):639-45
  • Koskinen EV. The repair of experimental fractures under the action of growth hormone, thyrotropin and cortisone. A tissue analytic, roentgenologic and autoradiographic study. Ann Chir Gynaecol Fenn Suppl 1959;48(90):1-48
  • Bail HJ, Raschke MJ, Kolbeck S, et al. Recombinant species-specific growth hormone increases hard callus formation in distraction osteogenesis. Bone 2002;30(1):117-24
  • Kolbeck S, Bail H, Schmidmaier G, et al. Homologous growth hormone accelerates bone healing: a biomechanical and histological study. Bone 2003;33(4):628-37
  • Raschke M, Kolbeck S, Bail H, et al. Homologous growth hormone accelerates healing of segmental bone defects. Bone 2001;29(4):368-73
  • Theyse LF, Oosterlaken-Dijksterhuis MA, van Doorn J, et al. Growth hormone stimulates bone healing in a critical-sized bone defect model. Clin Orthop Relat Res 2006;446:259-67
  • Nielsen HM, Bak B, Jorgensen PH, Andreassen TT. Growth hormone promotes healing of tibial fractures in the rat. Acta Orthop Scand 1991;62(3):244-7
  • Bak B, Jorgensen PH, Andreassen TT. The stimulating effect of growth hormone on fracture healing is dependent on onset and duration of administration. Clin Orthop Relat Res 1991;(264):295-301
  • Andreassen TT, Oxlund H. Local anabolic effects of growth hormone on intact bone and healing fractures in rats. Calcif Tissue Int 2003;73(3):258-64
  • Bak B, Andreassen TT. The effect of growth hormone on fracture healing in old rats. Bone 1991;12(3):151-4
  • Bak B, Jorgensen PH, Andreassen TT. Dose response of growth hormone on fracture healing in the rat. Acta Orthop Scand 1990;61(1):54-7
  • Guicheux J, Gauthier O, Aguado E, et al. Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: a rabbit study. J Bone Miner Res 1998;13(4):739-48
  • Hedner E, Linde A, Nilsson A. Systemically and locally administered growth hormone stimulates bone healing in combination with osteopromotive membranes: an experimental study in rats. J Bone Miner Res 1996;11(12):1952-60
  • Schlechter NL, Russell SM, Spencer EM, Nicoll CS. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 1986;83(20):7932-4
  • Steinbrech DS, Mehrara BJ, Rowe NM, et al. Gene expression of insulin-like growth factors I and II in rat membranous osteotomy healing. Ann Plast Surg 1999;42(5):481-7
  • Edwall D, Prisell PT, Levinovitz A, et al. Expression of insulin-like growth factor I messenger ribonucleic acid in regenerating bone after fracture: influence of indomethacin. J Bone Miner Res 1992;7(2):207-13
  • Mosekilde L, Bak B. The effects of growth hormone on fracture healing in rats: a histological description. Bone 1993;14(1):19-27
  • Carpenter JE, Hipp JA, Gerhart TN, et al. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. J Bone Joint Surg Am 1992;74(3):359-67
  • Northmore-Ball MD, Wood MR, Meggitt BF. A biomechanical study of the effects of growth hormone in experimental fracture healing. J Bone Joint Surg Br 1980;62(3):391-6
  • Laftman P, Holmstrom T, Kairento AL, et al. No effect of growth hormone on recovery of load-protected bone. Cortical bone mass and strength studied in rabbits. Acta Orthop Scand 1988;59(1):24-8
  • Herold HZ, Hurvitz A, Tadmor A. The effect of growth hormone on the healing of experimental bone defects. Acta Orthop Scand 1971;42(5):377-84
  • Harris JM 3rd, Bean DA, Banks HH. Effect of phosphate supplementation, thyrocalcitonin, and growth hormone on strength of fracture healing. Surg Forum 1975;26:519-21
  • Misol S, Samaan N, Ponseti IV. Growth hormone in delayed fracture union. Clin Orthop Relat R 1971;74:206-8
  • Weiss S, Henle P, Bidlingmaier M, et al. Systemic response of the GH/IGF-I axis in timely versus delayed fracture healing. Growth Horm IGF Res 2008;18(3):205-12
  • Lindholm RV, Koskinen EV, Puranen J, et al. Human growth hormone in the treatment of fresh fractures. Horm Metab Res 1977;9(3):245-6
  • Koskinen EV, Nieminen RA, Lindholm RV, et al. Human growth hormone in bone regeneration of non-healing fractures. Calcif Tissue Res 1977;22(Suppl):521-3
  • Boonen S, Rosen C, Bouillon R, et al. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 2002;87(4):1593-9
  • Hedstrom M, Saaf M, Brosjo E, et al. Positive effects of short-term growth hormone treatment on lean body mass and BMC after a hip fracture: a double-blind placebo-controlled pilot study in 20 patients. Acta Orthop Scand 2004;75(4):394-401
  • Van der Lely AJ, Lamberts SW, Jauch KW, et al. Use of human GH in elderly patients with accidental hip fracture. Eur J Endocrinol 2000;143(5):585-92
  • Weissberger AJ, Anastasiadis AD, Sturgess I, et al. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrinol (Oxf) 2003;58(1):99-107
  • Yeo AL, Levy D, Martin FC, et al. Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture. Growth Horm IGF Res 2003;13(6):361-70
  • Raschke M, Rasmussen MH, Govender S, et al. Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial. Eur J Endocrinol 2007;156(3):341-51
  • Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341(11):785-92
  • Bach MA, Rockwood K, Zetterberg C, et al. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. J Am Geriatr Soc 2004;52(4):516-23
  • Bak B, Jorgensen PH, Andreassen TT. Increased mechanical strength of healing rat tibial fractures treated with biosynthetic human growth hormone. Bone 1990;11(4):233-9
  • Golde DW, Bersch N, Li CH. Growth hormone: species-specific stimulation of erythropoiesis in vitro. Science 1977;196(4294):1112-3
  • Secchi C, Borromeo V. Structure and function of bovine growth hormone. Bovine growth hormone as an experimental model for studies of protein-protein interactions. J Chromatogr B Biomed Sci Appl 1997;688(2):161-77
  • Behncken SN, Rowlinson SW, Rowland JE, et al. Aspartate 171 is the major primate-specific determinant of human growth hormone. Engineering porcine growth hormone to activate the human receptor. J Biol Chem 1997;272(43):27077-83
  • Souza SC, Frick GP, Wang X, et al. A single arginine residue determines species specificity of the human growth hormone receptor. Proc Natl Acad Sci USA 1995;92(4):959-63
  • van Herpen H, Rijnberk A, Mol JA. Production of antibodies to biosynthetic human growth hormone in the dog. Vet Rec 1994;134(7):171
  • Amit T, Youdim MB, Hochberg Z. Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function? J Clin Endocrinol Metab 2000;85(3):927-32
  • Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998;(355 Suppl):S7-21
  • Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: which are the important molecules? Injury 2007;38(Suppl 1):S11-25
  • Li H, Bartold PM, Zhang CZ, et al. Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation? Endocrinology 1998;139(9):3855-62
  • Jansson JO, Albertsson-Wikland K, Eden S, et al. Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats. Acta Physiol Scand 1982;114(2):261-5
  • Clark RG, Jansson JO, Isaksson O, Robinson IC. Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats. J Endocrinol 1985;104(1):53-61
  • Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocr Metab 2001;86(5):1868-70
  • Carroll PV, Van den Berghe G. Safety aspects of pharmacological GH therapy in adults. Growth Horm IGF Res 2001;11(3):166-72
  • Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocr Metab 1998;83(2):379-81
  • Underwood LE, Attie KM, Baptista J. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. J Clin Endocr Metab 2003;88(11):5273-80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.